Kraemer M, Diehl RR, Diesner F, Berlit P, Khan N. Br J Neurosurg. 2012 Jun 29. [Epub ahead of print]

2. Gender Differences in Clinical Presentation and Treatment Outcomes in Moyamoya Disease.

Khan N, Achrol AS, Guzman R, Burns TC, Dodd R, Bell-Stephens T, Steinberg GK. Neurosurgery. 2012 Jun 20. [Epub ahead of print]

3. Analysis of TGFB1 in European and Japanese Moyamoya disease patients.

Liu C, Roder C, Schulte C, Kasuya H, Akagawa H, Nishizawa T, Yoneyama T, Okada Y, Khan N, Tatagiba M, Berg D, Krischek B.Eur J Med Genet. 2012 Jun 1. [Epub ahead of print]

4. Postoperative changes in the superficial temporal artery and the external carotid artery duplex sonography after extra-intracranial bypass surgery in European Moyamoya disease.

Kraemer M, Schuknecht B, Jetzer AK, Yonekawa Y, Khan N. Clin Neurol Neurosurg. 2012 Apr 3. [Epub ahead of print]

5. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy.

Kraemer M, Horn PA, Roder C, Khan N, Diehl RR, Berlit P, Heinemann FM. Acta Neurochir (Wien). 2012 Mar;154(3):445-54. Epub 2012 Jan 11.

6. [Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens]. 

Yonekawa Y. No Shinkei Geka. 2012 Jan;40(1):67-87. Japanese.

 7. Inheritance of moyamoya disease in a Caucasian family.

Kraemer M, Heinemann FM, Horn PA, Venker C, Berlit P, Krischek B, Khan N. Eur J Neurol. 2012 Mar;19(3):438-42. doi: 10.1111/j.1468-1331.2011.03536.x. Epub 2011 Oct 4.

8.Genetic and clinical characteristics of Moyamoya disease in Europeans. 

Krischek B, Kasuya H, Khan N, Tatagiba M, Roder C, Kraemer M. Acta Neurochir Suppl. 2011;112:31-4.

9. What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey. 

Kraemer M, Berlit P, Diesner F, Khan N. Eur J Neurol. 2012 Jan;19(1):163-7. doi: 10.1111/j.1468-1331.2011.03481.x. Epub 2011 Jul 20.

10. Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in Moyamoya angiopathy.

Khan N, Dodd R, Marks MP, Bell-Stephens T, Vavao J, Steinberg GK. Cerebrovasc Dis. 2011;31(2):147-53. Epub 2010 Dec 4.

 11.Analysis of ACTA2 in European Moyamoya disease patients.

Roder C, Peters V, Kasuya H, Nishizawa T, Wakita S, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B. Eur J Paediatr Neurol. 2011 Mar;15(2):117-22. Epub 2010 Oct 20.

12. Genetics of Moyamoya disease. 

Roder C, Nayak NR, Khan N, Tatagiba M, Inoue I, Krischek B. J Hum Genet. 2010 Nov;55(11):711-6. Epub 2010 Aug 26.

13. Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans.

Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B. Childs Nerv Syst. 2011 Feb;27(2):245-52. Epub 2010 Aug 6.

14. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients.

Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B. Acta Neurochir (Wien). 2010 Dec;152(12):2153-60. Epub 2010 Jun 23.

15. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype.

Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI Jr, Steinberg GK. Am J Med Genet A. 2010 Apr;152A(4):960-5.

16. Moyamoya angiopathy in Europe: the beginnings in Zurich, practical lessons learned, increasing awareness and future perspectives.

Khan N, Yonekawa Y. Acta Neurochir Suppl. 2008;103:127-30. Review.

17. Moyamoya syndrome associated with hemolytic anemia due to Hb Alesha.

Brockmann K, Stolpe S, Fels C, Khan N, Kulozik AE, Pekrun A. J Pediatr Hematol Oncol. 2005 Aug;27(8):436-40.

18. Moyamoya angiopathy in Europe.

Khan N, Yonekawa Y. Acta Neurochir Suppl. 2005;94:149-52.

 19. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.

Weber B, Westera G, Treyer V, Burger C, Khan N, Buck A. J Nucl Med. 2004 Aug;45(8):1344-50.

20. Moyamoya angiopathy with dolichoectatic internal carotid arteries, patent ductus arteriosus and pupillary dysfunction: a new genetic syndrome?

Khan N, Schinzel A, Shuknecht B, Baumann F, Østergaard JR, Yonekawa Y. Eur Neurol. 2004;51(2):72-7. Epub 2004 Jan 16.

21. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.

Khan N, Schuknecht B, Boltshauser E, Capone A, Buck A, Imhof HG, Yonekawa Y. Acta Neurochir (Wien). 2003 Dec;145(12):1061-71; discussion 1071. Epub 2003 Dec 4.

Published Books

1. Changing Aspects in Stroke Surgery : Aneurysms, dissection, Moyamoya angiopathy and EC-IC BypassYonekawa Y,  Tsukahara T, Valavanis a, Khan N.

2008, VIII, 141p., Hardcover, Springer Verlag

ISBN: 978-3-211-76588-3